Systa Pharma Labs Private Limited, a active private limited company, was established on 27 December 1988 in Trichur, Kerala, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24231KL1988PTC005263. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹4.00 Cr.
Formerly known as Chethana Drugs And Chemicals Private Limited. It upholds a compliant status. Its leadership includes Vijayasree (Managing Director), Variketta Mallissery Sujatha Namboodiri (Director), Bhat Muniyankula Venkateswaran Sambhu (Director). Past directors included Vijayasree, Avanoormana Damodaran Nambudiri, Ankarath Krishnadasan. It holds no open charges and ₹3.70 M settled loans. Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at Velakkodemundoor, Trichur, Kerala, 680541.
U24231KL1988PTC005263
005263
27 December 1988
₹5.00 Cr
₹4.00 Cr
Roc Ernakulam
Unlisted
Active
Explore comprehensive insights into Systa Pharma Labs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vijayasree | Managing Director | 25 Jan 2010 | Current |
| Variketta Mallissery Sujatha Namboodiri | Director | 25 Jan 2010 | Current |
| Bhat Muniyankula Venkateswaran Sambhu | Director | 15 Dec 2009 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 07 May 2012 | Past |
| Pramod Abcsdd | Director | 01 Apr 2010 | Past |
| Pramod Abcsdd | Director | 01 Apr 2010 | Past |
| Pramod Abcsdd | Director | 01 Apr 2010 | Past |
| Pramod Abcsdd | Director | 01 Apr 2010 | Past |
| Pramod Abcsdd | Director | 12 May 2009 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Systa Pharma Labs Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 97.16% decrease. The company also saw a substantial fall in profitability, with a 49.32% decrease in profit. The company's net worth observed a substantial decline by a decrease of 75.07%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Systa Pharma Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹3,700,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Jan 2002 | Canara Bank | ₹1.60 M | Satisfied |
| 17 Nov 1995 | Canara Bank | ₹0.10 M | Satisfied |
| 17 Nov 1995 | Canara Bank | ₹2.00 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Systa Pharma Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Systa Pharma Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Systa Pharma Labs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Systa Pharma Labs Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was recorded as a recent event.
Systa Pharma Labs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Ernakulam. was recorded as a recent event.
Progress on A charge registered on 17 Nov 1995 via Charge ID 90016480 with Canara Bank was fully satisfied on 13 Jul 2010. was documented.
The activity A charge registered on 17 Nov 1995 via Charge ID 80035561 with Canara Bank was fully satisfied on 13 Jul 2010. was completed.
Progress on Vijayasree was appointed as a Managing Director was appointed as a Managing Director on 25 Jan 2010 & has been associated with this company since 15 years 11 months . was documented.
Progress on Variketta Mallissery Sujatha Namboodiri was appointed as a Director was appointed as a Director on 25 Jan 2010 & has been associated with this company since 15 years 11 months . was documented.
The CIN of Systa Pharma Labs Private Limited is U24231KL1988PTC005263.
Systa Pharma Labs Private Limited is headquartered at Velakkodemundoor, Trichur, Kerala, 680541.
Systa Pharma Labs Private Limited was incorporated on 27 December 1988.
The current directors of Systa Pharma Labs Private Limited are
The primary industry of Systa Pharma Labs Private Limited is Pharma.
Systa Pharma Labs Private Limited is unlisted.
The authorized capital of Systa Pharma Labs Private Limited is ₹5.00 Cr, and the paid-up capital is ₹4.00 Cr.
The compliance status of Systa Pharma Labs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX